Evaluation of Clinical Benefits of In-House Walking in T2D Indian Housewives

被引：0
|
作者：
Shankhdhar, Kshitij
Shankhdhar, Lakshmi Kant
Shankhdhar, Uma
Shankhdhar, Smita
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A285 / A285
页数：1
相关论文
共 50 条
  • [21] Understanding and Addressing Enrollment Challenges in Pediatric T2D Clinical Trials Compared with T1D
    Terry, Amanda M.
    Bollepalli, Sureka
    Smith, Laura
    Walker, Ashby F.
    Gal, Robin L.
    Beaulieu, Lindsey C.
    Edelen, Rachel C.
    Less, Joane E.
    DIABETES, 2018, 67
  • [22] Time of Insulin Initiation, Duration of Disease and Onset of Erectile Dysfunction in Indian Men With T2D
    Shankar, Arun
    Jothydev, Sunitha
    Gopalakrishnan, Gopikakrishnan
    Lally, Jayasree
    Kesavadev, Jothydev
    DIABETES, 2013, 62 : A697 - A697
  • [23] Possible link between autoimmunity and clinical features in T2D children and adolescents
    Gottschalk, Michael
    Danne, Thomas
    Fuerst-Recktenwald, Sabine
    DIABETES, 2007, 56 : A700 - A700
  • [24] Causes of Blinded CGM Failure during Clinical Trials in Patients with T2D
    Saldivar-Salazar, Sergio
    Testa, Marcia A.
    Hayes, Johanna F.
    Simonson, Donald C.
    DIABETES, 2019, 68
  • [25] Clinical Impact of Treatment Intensification in Patients with T2D Uncontrolled with Basal Insulin
    Buysman, Erin
    Fan, Tao
    Blauer-Peterson, Cori
    Miller, Lesley-Ann
    DIABETES, 2017, 66 : A267 - A267
  • [26] Clinical Trial of the Use of Sitagliptin in Pediatric Patients with T2D: Baseline Characteristics
    Jalaludin, Muhammad Y.
    Garcia, Raymundo
    Newfield, Ron S.
    Rosario, Carmen A.
    Samoilova, Yulia
    Shehadeh, Naim
    Zhang, Yilong
    Scherer, Lynn W.
    Saha, Chandan K.
    Engel, Samuel S.
    Zeitler, Philip
    Kaufman, Keith D.
    Shankar, R. Ravi
    DIABETES, 2019, 68
  • [27] Effect of a family and interdisciplinary intervention to prevent T2D: randomized clinical trial
    Katya Vargas-Ortiz
    Georgina Lira-Mendiola
    Claudia M. Gómez-Navarro
    Katya Padilla-Estrada
    Fabiola Angulo-Romero
    José M. Hernández-Márquez
    Ana K. Villa-Martínez
    Jessica N. González-Mena
    Maciste H. Macías-Cervantes
    Maria de Lourdes Reyes-Escogido
    Rodolfo Guardado-Mendoza
    BMC Public Health, 20
  • [28] Effect of a family and interdisciplinary intervention to prevent T2D: randomized clinical trial
    Vargas-Ortiz, Katya
    Lira-Mendiola, Georgina
    Gomez-Navarro, Claudia M.
    Padilla-Estrada, Katya
    Angulo-Romero, Fabiola
    Hernandez-Marquez, Jose M.
    Villa-Martinez, Ana K.
    Gonzalez-Mena, Jessica N.
    Macias-Cervantes, Maciste H.
    de Lourdes Reyes-Escogido, Maria
    Guardado-Mendoza, Rodolfo
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [29] Assessment of genetic and clinical factors in T2D susceptibility among patients with hypertension
    Al Hageh, Cynthia
    O'Sullivan, Siobhan
    Henschel, Andreas
    Chacar, Stephanie
    Hantouche, Mireille
    Nader, Moni
    Zalloua, Pierre A.
    ACTA DIABETOLOGICA, 2024, 61 (10) : 1259 - 1266
  • [30] Metabolic benefits of adding pioglitazone to patients with Type 2 diabetes (T2D) already optimized on insulin therapy
    Mattoo, V
    Eckland, D
    Widel, M
    Duran, S
    Fajardo, C
    Strand, J
    Knight, D
    Oakley, D
    Tan, M
    DIABETOLOGIA, 2004, 47 : A59 - A59
12345